Bacteroides ovatus
Selected indexed studies
- Bacteroides ovatus alleviates dysbiotic microbiota-induced graft-versus-host disease. (Cell Host Microbe, 2024) [PMID:39214085]
- Glucomannan promotes Bacteroides ovatus to improve intestinal barrier function and ameliorate insulin resistance. (Imeta, 2024) [PMID:38868507]
- The Metabolite Indole-3-Acetic Acid of Bacteroides Ovatus Improves Atherosclerosis by Restoring the Polarisation Balance of M1/M2 Macrophages and Inhibiting Inflammation. (Adv Sci (Weinh), 2025) [PMID:39840614]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Bacteroides species differentially modulate depression-like behavior via gut-brain metabolic signaling. (2022) pubmed
- Bacteroides ovatus alleviates dysbiotic microbiota-induced graft-versus-host disease. (2024) pubmed
- Glucomannan promotes Bacteroides ovatus to improve intestinal barrier function and ameliorate insulin resistance. (2024) pubmed
- The Metabolite Indole-3-Acetic Acid of Bacteroides Ovatus Improves Atherosclerosis by Restoring the Polarisation Balance of M1/M2 Macrophages and Inhibiting Inflammation. (2025) pubmed
- Microbiota-derived lysophosphatidylcholine alleviates Alzheimer's disease pathology via suppressing ferroptosis. (2025) pubmed
- Gut Bacteroides ovatus ameliorates renal fibrosis by promoting the production of HDCA through upregulation of Clostridium scindens. (2024) pubmed
- Bacteroides ovatus-mediated CD27(-) MAIT cell activation is associated with obesity-related T2D progression. (2022) pubmed
- Bacteroides ovatus alleviates dysbiotic microbiota-induced intestinal graft-versus-host disease. (2023) pubmed
- Bifidobacterium breve synergizes with Akkermansia muciniphila and Bacteroides ovatus to antagonize Clostridioides difficile. (2025) pubmed
- Bacteroides ovatus Has the Potential to Be a Next-Generation Probiotic Strain. (2026) pubmed